Bank of New York Mellon Corp - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 67 filers reported holding SYNERON MEDICAL LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q1 2015$304,000
-62.0%
24,563
-71.4%
0.00%
Q4 2014$801,000
+5.7%
85,903
+13.5%
0.00%
Q3 2014$758,000
-62.9%
75,670
-61.8%
0.00%
Q2 2014$2,042,000
+65.7%
197,840
+100.0%
0.00%
Q1 2014$1,232,000
+18.7%
98,920
+17.2%
0.00%
Q4 2013$1,038,000
+28.3%
84,430
-9.9%
0.00%
Q3 2013$809,000
+21.8%
93,753
+22.8%
0.00%
Q2 2013$664,00076,3200.00%
Other shareholders
SYNERON MEDICAL LTD shareholders Q4 2013
NameSharesValueWeighting ↓
HealthInvest Partners AB 706,107$5,931,0005.46%
NORTH TIDE CAPITAL, LLC 3,500,000$29,400,0005.03%
Senvest Management, LLC 3,777,775$31,733,0002.26%
Kenmare Capital Partners, L.L.C. 269,839$2,267,0001.72%
Camber Capital Management LP 2,347,593$19,720,0001.03%
DALTON GREINER HARTMAN MAHER & CO 1,785,826$15,001,0000.88%
PERRITT CAPITAL MANAGEMENT INC 425,170$3,571,0000.87%
Profit Investment Management, LLC 88,777$746,0000.70%
DAFNA Capital Management LLC 85,947$722,0000.63%
Lapides Asset Management, LLC 396,800$3,333,0000.60%
View complete list of SYNERON MEDICAL LTD shareholders